Samuel Myllykangas

Samuel Myllykangas is an experienced leader in genetics and biotechnology, currently serving as General Manager and Executive Director of Global Specialty Genetics at Quest Diagnostics since August 2021. Prior to this, Samuel held several key roles at Blueprint Genetics from November 2011 to March 2023, including Managing Director, Executive Director of Strategy, Chief Strategy Officer, Chief Operating Officer, and CTO, where extensive oversight of strategic initiatives and the genetic testing division was conducted. A co-founder and first CEO of Blueprint Genetics, Samuel also has a significant academic background, having served as an Adjunct Professor and Principal Investigator at the University of Helsinki, and as a Postdoctoral Research Fellow at Stanford University, where innovative sequencing technologies were developed. Educational credentials include a PhD in Oncology and Cancer Biology from the University of Helsinki and a Master of Science in Microbiology from the same institution.